These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 9500542)

  • 81. Intrahepatic cholestasis, sometimes benign recurrent.
    García-Romero R; Morlan-Herrador L; Ros-Arnal I; Miramar MD; Molera-Busons C
    Gastroenterol Hepatol; 2021 Dec; 44(10):719-720. PubMed ID: 33248179
    [No Abstract]   [Full Text] [Related]  

  • 82. Cholestasis Familiaris Groenlandica/Byler-like disease in Greenland--a population study.
    Eiberg H; Nørgaard-Pedersen B; Nielsen IM
    Int J Circumpolar Health; 2004; 63 Suppl 2():189-91. PubMed ID: 15736649
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Progressive Familial Intrahepatic Cholestasis Type 1 Associated with Cherry-Red Spots in an Infant: A First Case Report.
    Alzebaidi S; Alghamdi Y; Alghamdi A; Hasosah M; Alsharef E
    Cureus; 2020 Dec; 12(12):e12226. PubMed ID: 33376662
    [TBL] [Abstract][Full Text] [Related]  

  • 84. New paradigms of USP53 disease: normal GGT cholestasis, BRIC, cholangiopathy, and responsiveness to rifampicin.
    Alhebbi H; Peer-Zada AA; Al-Hussaini AA; Algubaisi S; Albassami A; AlMasri N; Alrusayni Y; Alruzug IM; Alharby E; Samman MA; Ayoub SZ; Maddirevula S; Peake RWA; Alkuraya FS; Wali S; Almontashiri NAM
    J Hum Genet; 2021 Feb; 66(2):151-159. PubMed ID: 32759993
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Closing in on a "familial cholestasis gene".
    Wagstaff J; Jonas MM
    Hepatology; 1995 Nov; 22(5):1611-3. PubMed ID: 7590684
    [No Abstract]   [Full Text] [Related]  

  • 86. Heteromeric interactions required for abundance and subcellular localization of human CDC50 proteins and class 1 P4-ATPases.
    van der Velden LM; Wichers CG; van Breevoort AE; Coleman JA; Molday RS; Berger R; Klomp LW; van de Graaf SF
    J Biol Chem; 2010 Dec; 285(51):40088-96. PubMed ID: 20947505
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Liver disease without flipping: new functions of ATP8B1, the protein affected in familial intrahepatic cholestasis type 1.
    Dawson PA
    Hepatology; 2010 Jun; 51(6):1885-7. PubMed ID: 20512981
    [No Abstract]   [Full Text] [Related]  

  • 88. Mining the idiopathic genetic cholestasis syndrome.
    Chen HL
    J Gastroenterol Hepatol; 2013 Mar; 28(3):389-91. PubMed ID: 23441719
    [No Abstract]   [Full Text] [Related]  

  • 89. [Familial incidence of benign recurrent intrahepatic cholestasis].
    Simon L; Bajtai A; Szabó E; Figus IA
    Orv Hetil; 1980 Nov; 121(45):2771-4. PubMed ID: 7208022
    [No Abstract]   [Full Text] [Related]  

  • 90. [Molecular diagnosis of hereditary canalicular cholestasis and familial hyperbilirubinemias].
    Jirsa M
    Cas Lek Cesk; 2011; 150(1):7-13. PubMed ID: 21404481
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Genetic mutations causing hereditary cholestasis.
    Denson LA; Karpen SJ
    J Pediatr Gastroenterol Nutr; 1999 Apr; 28(4):451-2. PubMed ID: 10204515
    [No Abstract]   [Full Text] [Related]  

  • 92. [Benign recurrent intrahepatic cholestasis].
    Putterman C; Keidar S
    Harefuah; 1987 Aug; 113(3-4):70-2. PubMed ID: 3319835
    [No Abstract]   [Full Text] [Related]  

  • 93. Increased nuchal translucency in arthrogryposis, renal dysfunction and cholestasis (ARC) syndrome and discovery of a Portuguese specific mutation in the VPS33B gene.
    Sanseverino MT; de Souza CF; Gissen P; Sordi AO; Magalhães JA; Schüler-Faccini L
    Ultrasound Obstet Gynecol; 2006 Aug; 28(2):233-4. PubMed ID: 16758438
    [No Abstract]   [Full Text] [Related]  

  • 94. Idiopathic benign recurrent cholestasis in second cousins.
    Muñoz AI; Miranda F; Díaz de Silva A; Velázquez J
    Bol Asoc Med P R; 1983 Jun; 75(6):282-3. PubMed ID: 6577876
    [No Abstract]   [Full Text] [Related]  

  • 95. Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis.
    Xie S; Wei S; Ma X; Wang R; He T; Zhang Z; Yang J; Wang J; Chang L; Jing M; Li H; Zhou X; Zhao Y
    Front Pharmacol; 2023; 14():1173542. PubMed ID: 37324459
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Hyperthyroidism as a Potential Trigger for Benign Recurrent Intrahepatic Cholestasis.
    Halawi A; Bitar R; Ibrahim N
    ACG Case Rep J; 2020 Jul; 7(7):e00423. PubMed ID: 32766365
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Mutation specific drug therapy for progressive familial or benign recurrent intrahepatic cholestasis: a new tool in a near future?
    Gonzales E; Jacquemin E
    J Hepatol; 2010 Aug; 53(2):385-7. PubMed ID: 20537422
    [No Abstract]   [Full Text] [Related]  

  • 98. In search of a gene for hereditary cholestasis.
    Sela-Herman S; Bull L; Lomri N; Rahmaoui C; Luther T; Hammerman P; Genant J; Freimer N; Scharschmidt B
    Biochem Mol Med; 1996 Dec; 59(2):98-103. PubMed ID: 8986630
    [No Abstract]   [Full Text] [Related]  

  • 99. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis.
    Strautnieks SS; Bull LN; Knisely AS; Kocoshis SA; Dahl N; Arnell H; Sokal E; Dahan K; Childs S; Ling V; Tanner MS; Kagalwalla AF; Németh A; Pawlowska J; Baker A; Mieli-Vergani G; Freimer NB; Gardiner RM; Thompson RJ
    Nat Genet; 1998 Nov; 20(3):233-8. PubMed ID: 9806540
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The spectrum of novel ABCB11 gene variations in children with progressive familial intrahepatic cholestasis type 2 in Pakistani cohorts.
    Riaz H; Zheng B; Zheng Y; Liu Z; Gu HM; Imran M; Yaqoob T; Bhinder MA; Zhang DW; Zahoor MY
    Sci Rep; 2024 Aug; 14(1):18876. PubMed ID: 39143102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.